Hematological Oncology · 1998 · 30 citations · 11 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyChemotherapy In Hematologic MalignanciesCombination Cancer TherapyCombination ChemotherapyHematologic Malignancy TherapyOncology PharmacologyToxicity ManagementHodgkin Lymphoma TherapyHodgkin Lymphoma TreatmentLymphoma ChemotherapyLymphoma Treatment ResponseNon-hodgkin Lymphoma TherapyNon-hodgkin Lymphoma Treatment
Seventeen patients with previously treated Hodgkin's disease or non-Hodgkin's lymphoma (NHL) were treated with single-agent vinorelbine (Navelbine Pierre-Fabre Medicament) in an open study to assess the activity of this new-generation vinca alkaloid. Responses were obtained in four out of eight patients with Hodgkin's disease and four out of nine patients with NHL, including four patients who had been previously treated with high-dose therapies. Toxicity was very mild. The study demonstrates worthwhile activity and justifies the inclusion of vinorelbine in combination therapies for lymphoma.
11
Reporting results of cancer treatment
A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations
WHO Handbook for Reporting Results of Cancer Treatment
M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text
Medicine, Oncology, Cancer Control +11
The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s disease
Christophe Fermé, Y Bastion, Éric Lepage et al. · Annals of Oncology · 1995 · 124 citations · Full text
Medicine, Oncology, Chemotherapy +11